Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. MTZ Clinical Research (Pratia Network)

Source: Site record.

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

MTZ Clinical Research, part of the Pratia Network, is a specialized clinical research center focused on conducting high-quality clinical trials across a range of therapeutic areas. Based in Poland, MTZ Clinical Research operates as part of an international network of research sites, enabling efficient patient recruitment and standardized study execution across multiple countries. The center is involved in Phase II–IV clinical trials, working closely with pharmaceutical companies, contract research organizations (CROs), and investigators to evaluate the safety and efficacy of new drugs and medical interventions. It follows strict international guidelines, including Good Clinical Practice (GCP), ensuring ethical conduct and reliable data generation. MTZ Clinical Research emphasizes patient-centric approaches, streamlined operations, and rapid study start-up timelines. Through its integration within the Pratia Network, it benefits from shared expertise, advanced infrastructure, and…

Source: Trial-derived.
67Total Trials
Source: Trial-derived.
26Recruiting Trials
Source: Trial-derived.
47Active Trials
Source: Trial-derived.
15Completed Trials
Source: Trial-derived.
78Unique Conditions
Source: Trial-derived.
48Unique Sponsors

Conditions

Source: Trial-derived. Migraine (9)Source: Trial-derived. Focal Epilepsy (4)Source: Trial-derived. Chronic Lymphocytic Leukemia (CLL) (2)Source: Trial-derived. Depressive Disorder, Major (2)Source: Trial-derived. Diabetes Mellitus, Type 1 (2)Source: Trial-derived. Focal Onset Seizures (2)Source: Trial-derived. Heart Failure (2)Source: Trial-derived. Paroxysmal Nocturnal Hemoglobinuria (2)

Sponsors

Source: Trial-derived. H. Lundbeck A/S (6)Source: Trial-derived. Pfizer (6)Source: Trial-derived. Amgen (5)Source: Trial-derived. Janssen Research & Development, LLC (5)Source: Trial-derived. AbbVie (4)Source: Trial-derived. Boehringer Ingelheim (4)Source: Trial-derived. Biohaven Therapeutics Ltd. (3)Source: Trial-derived. Eli Lilly and Company (3)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Enhanced liver fibrosis testing
Source: AI-inferred. Quantitative liver fat measurement
Source: AI-inferred. Unstimulated salivary flow measurement (sialometry)
Source: AI-inferred. Visual acuity testing